Aarti Pharmalabs Limited Capital Reinvestment Ratio
Aarti Pharmalabs Limited capital reinvestment ratio. Aarti Pharmalabs Limited (AARTIPHARM) has a Capital Reinvestment Ratio of 0.32x as of March 2023, meaning it reinvests 0% of its operating cash flow (Rs1.03 Billion) in capital expenditures (Rs331.54 Million). Check Aarti Pharmalabs Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Aarti Pharmalabs Limited (2023–2025)
Capital reinvestment ratio of Aarti Pharmalabs Limited from 2023 to 2025. This chart tracks Aarti Pharmalabs Limited's Capital Reinvestment Ratio across 3 annual periods. Also explore AARTIPHARM net asset momentum to track the company's year-over-year net asset growth rate.
Aarti Pharmalabs Limited Capital Reinvestment Ratio by Year (2023–2025)
Aarti Pharmalabs Limited capital reinvestment ratio by year from 2023 to 2025. For the full cash flow conversion analysis, see Aarti Pharmalabs Limited cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.21x | Rs3.32 Billion | Rs4.02 Billion | ▲ +32.0% |
| 2024 | 0.92x | Rs2.16 Billion | Rs1.99 Billion | ▲ +101.9% |
| 2023 | 0.45x | Rs2.63 Billion | Rs1.20 Billion | — |